Search Results 901-910 of 18967 for Neutrophil

1. Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) - Mayo Clinic

   - Absolute neutrophil count (ANC) >= 1,000/mm^3 - Platelet count >= 100,000/mm^3 - Creatinine =< 1.5 x upper limit of normal (ULN) - Aspartate ...

2. Low white blood cell count When to see a doctor - Mayo Clinic

   In general, for adults, a count lower than 3,500 white blood cells per microliter of blood is considered low. For children, an expected count depends on the age ...

3. Clinical trials - Oncology (Medical)

   MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

4. A Study of XmAb ®18087 in Subjects With NET and GIST - Mayo Clinic

   Absolute neutrophil count < 1.0 x 10^9/L. Aspartate aminotransferase (AST) ≥ 3 × upper limit of normal (ULN), or if subject has known liver metastases, AST ...

5. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

   Absolute neutrophil count ≥ 1.5 × 10^9 /L;; Platelets ≥ 100 × 10^9 /L;; Hemoglobin ≥ 9.0 g/dL;; International Normalized Ratio (INR) ≤ 1.5;; Creatinine ...

6. A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 x 10^9/L;; Platelets count ≥ 100 x 10^9/L;; Hemoglobin ≥ 10 g/dL (eligibility level for hemoglobin may be met by ...

7. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

   ... neutrophil count (ANC) ≥ 1000/uL; For patients with solid tumors without bone marrow involvement: platelet count ≥ 100,000/uL (transfusion independent ...

8. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,000/mm^3. Platelet count ≥ 100,000/mm^3; Hemoglobin ≥ 9.0 g/dL. Calculated (Calc.) creatinine clearance ≥ 30 mL/min ...

9. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,500/mm³; Peripheral platelet count ≥ 100,000/mm³; Hemoglobin (HgB) > 9.0 g/dL; Total bilirubin ≤ 1.5 times upper limit ...

10. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Absolute neutrophil count ≥ 1.5 × 10^9/L;; Platelets ≥ 100 × 10^9/L;; Hemoglobin ≥ 9 g/dL;; Chemistries as follows: Potassium ≥ lower limit of normal (LLN) ...